Caligan Partners’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,052,538
Closed -$24.3M 17
2025
Q1
$24.3M Hold
3,052,538
5.06% 6
2024
Q4
$16.6M Buy
+3,052,538
New +$16.6M 4.2% 8